Health and Healthcare

National Employee Morale Day At Boston Scientific (BSX)

Boston Scientific (NYSE:BSX), the worst run of the large medical device and pharma firms based in the US, announced an operating loss for the fourth quarter of 2009 of $1.23 billion. The company’s guidance was poor which pushed shares down 7% in active trading to $7.61. The bad news was on top of an announcement last week that Boston Scientific will pay Johnson & Johnson (NYSE:JNJ) $1.7 billion to settle patent disputes. The New York Times wrote “The figure appears to be the largest sum ever paid to resolve patent litigation over a medical device.”

Boston Scientific also announced that it will cut 8% to 10% of its staff. The firm said the moves will save between $200 million and $250 million over the 2010 to 2011 period. It is the latest of a number of job cuts since the company bought Guidant in 2006.

It is difficult to see how CEO Ray Elliott will keep his job in the process. Elliott has only been with the company since last year, but the stock is down 40% during the last eight quarters. Elliott’s turnaround program has been a failure.

A great deal of the blame also goes to Pete M. Nicholas, the company’s co-founder,  who has been Chairman of the Board since 1995. Boston Scientific shares traded for $12 in 1995, 40% more than the share price is now.

Douglas A. McIntyre

In 20 Years, I Haven’t Seen A Cash Back Card This Good

After two decades of reviewing financial products I haven’t seen anything like this. Credit card companies are at war, handing out free rewards and benefits to win the best customers. 

A good cash back card can be worth thousands of dollars a year in free money, not to mention other perks like travel, insurance, and access to fancy lounges.

Our top pick today pays up to 5% cash back, a $200 bonus on top, and $0 annual fee. Click here to apply before they stop offering rewards this generous. 

 

Flywheel Publishing has partnered with CardRatings for our coverage of credit card products. Flywheel Publishing and CardRatings may receive a commission from card issuers.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.

AI Portfolio

Discover Our Top AI Stocks

Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.

You can follow him investing $500,000 of his own money on our top AI stocks for free.